Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2002-10-21
2010-10-12
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S184100, C424S185100, C424S190100, C424S234100, C435S004000, C435S007100, C435S007200, C530S300000, C530S350000
Reexamination Certificate
active
07811588
ABSTRACT:
A method is provided for identifying mycobacterial genes the expression of which is down-regulated during a stationary phase culture of mycobacteria under nutrient-starving conditions when compared with an exponential phase culture of mycobacteria under culture conditions that are not nutrient-starving and that support exponential growth of said mycobacteria. The described method optionally provides for identifying mycobacterial genes that are simultaneously down-regulated under low dissolved oxygen tension conditions. The down-regulated genes of the present invention form the basis of nucleic acid vaccines, or provide targets to allow preparation of attenuated mycobacteria for vaccines against mycobacterial infections. Similarly, peptides encoded by said down-regulated genes are employed in vaccines. In a further embodiment, the identified genes/peptides provide the means for identifying the presence of a mycobacterial infection in a clinical sample by nucleic acid probe or antibody detection.
REFERENCES:
patent: 6573361 (2003-06-01), Bunkers et al.
patent: 6583266 (2003-06-01), Smith et al.
patent: 6892139 (2005-05-01), Eisenberg et al.
patent: 2004/0241826 (2004-12-01), James et al.
patent: 2004/0254349 (2004-12-01), James et al.
patent: WO 96/17951 (1996-06-01), None
patent: WO98/16645 (1998-04-01), None
McMurray, D. Recent progress in the development and testing of vaccines against human tuberculosis. Internation Journal for Parasitology, vol. 33, pp. 547-554, 2003.
von Reyn, C.F., et al. New vaccines for the prevention of tuberculosis. Clinical Infectious Diseases, Vo. 35, pp. 465-474, 2002.
Orme, I.M., et al. Tuberculosis vaccine development: recent progress. Trends in Microbiology, vol. 9, No. 3, pp. 115-118, 2001.
Honore, N., et al, “Nucleotide sequence of the first cosmid from theMycobacterium lepraegenome project: structure and function of the Rif—Str regions”, Molecular Microbiology, vol. 7, No. 2, pp. 207-214, 1993.
Ohara, N., et al, “Isolation and amino acid sequence of the 30S ribosomal protein S19 fromMycobacterium bovisBCG”, FEBS Letters, vol. 331, No. 1,2, pp. 9-14, 1993.
Cole, S.T., et al., “Deciphering the biology ofMycobacterium tuberculosisfrom the complete genome sequence,”Nature 393:537-544 (with 10 sheets of Table 1. Functional classification ofMycobacterium tuberculosisprotein coding genes), Macmillan Publishers Ltd. (1998).
Cole, S.T., et al., “Deciphering the biology ofMycobacterium tuberculosisfrom the complete genome sequence,” Erratum inNature 396:190-198, Macmillan Publishers Ltd. (1998).
Nutter, B. and Dick, T., “Up-regulation ofnarX, encoding a putative ‘fused nitrate reductase’ in anaerobic dormantMycobacterium bovisBCG,”Fems Microbiol. Lett. 178:63-69, Elsevier Science B.V. (1999).
Murugasu-Oei, B., et al., “Upregulation of stress response genes and ABC transporters in anaerobic stationary-phaseMycobacterium smegmatis,” Mol. Gen. Genet. 262:677-682, Springer-Verlag (1999).
Sambrook, J., et al., “Construction and Analysis of cDNA Libraries,” inMolecular Cloning, A Laboratory Manual, 2ndEdition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 8.48-8.49 (1989).
Sherman, D.R. et al., “Regulation of theMycobacterium tuberculosishypoxic response gene encoding α-crystallin,”Proc. Natl. Acad. Sci. USA 98:7534-7539, National Academy of Sciences (Jun. 19, 2001).
Talaat, A.M. et al., “Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis,”Nat. Biotechnol. 18:679-682, Macmillan Publishers Ltd. (Jun. 2000).
EMBL Online Database Sequence, Accession No. O53607, “Putative cellulase ofMycobacterium tuberculosis,” Created Jun. 1, 1998.
Daniel, T.M., “Soluble Mycobacterial Antigens,” inThe Mycobacteria—A Sourcebook, Part A, Kubica, G.P., and Wayne, L.G., eds., Marcel Dekker, Inc., New York, pp. 417-465 (1984).
Stedman's Medical Dictionary, 26thEdition, Williams & Wilkins, Baltimore, MD, p. 868 (1995).
Ojha, A.K., et al., “High Intracellular Level of Guanosine Tetraphosphate inMycobacterium smegmatisChanges the Morphology of the Bacterium,”Infection and Immunity 68:4084-4091, American Society for Microbiology (2000).
Smeulders, M.J., et al., “Adaption ofMycobacterium smegmatisto Stationary Phase,”J.Bacteriol. 181:270-283, American Society for Microbiology (1999).
Flynn, J.L. and Chan, J., “Tuberculosis: Latency and Reactivation,”Infect. Immun. 69:4195-4201, American Society for Microbiology (Jul. 2001).
Ohno, H. and Kohno, S., “Trends in Research Concerning Pulmonary Myocobacteriosis Genome and Pathogenicity of Tuberculosis”Resp. Molec. Med. 6:202-209, Akira (May 2002.
Unverified English Language Translation of Document NPL6, Ohno, H. and Kohno, S., “Trends in Research Concerning Pulmonary Myocobacteriosis Genome and Pathogenicity of Tuberculosis,”Resp. Molec. Med. 6:202-209, Akira (May 2002).
Wilson, M., et al., “Exploring drug-induced alterations in gene expression inMycobacterium tuberculosisby microarray hybridization,”Proc. Natl. Acad. Sci. U.S.A. 96:12833-12838, National Academy of Science (1999).
Hampshire Tobias
James Brian William
Marsh Philip
Evan Law Group LLC
Health Protection Agency
Swartz Rodney P.
LandOfFree
Mycobacterial genes down-regulated during latency does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycobacterial genes down-regulated during latency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterial genes down-regulated during latency will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177592